Rashid Khan in Mishawaka, Indiana

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 2005
The Primary Medical Specialty for Rashid Khan is listed as: Medical Oncology
Approximate Years of Experience: 19
PAC (PECOS ID)#: 0042447245
NPI #: 1649446444
NPI Created On: 05/01/2008
NPI Last Updated Listed as: 01/03/2018
Primary Taxonomy Code: 207RH0003X
License Number:
01075445A
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Celtic Insurance Company
• Humana
• CareSource
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Hindi.

Services and Procedures include:

1. Ct scan chest with contrast
2. Ct scan of abdomen and pelvis with contrast
3. Nuclear medicine study with ct imaging skull base to mid-thigh
4. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
5. Infusion into a vein for therapy, prevention, or diagnosis
6. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
7. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
8. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
9. Infusion of chemotherapy into a vein up to 1 hour
10. Infusion of chemotherapy into a vein
11. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
12. New patient office or other outpatient visit, typically 45 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Initial hospital inpatient care, typically 50 minutes per day
16. Subsequent hospital inpatient care, typically 15 minutes per day
17. Subsequent hospital inpatient care, typically 25 minutes per day
18. Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
19. Injection, darbepoetin alfa, 1 microgram (non-esrd use)
20. Injection, denosumab, 1 mg